Short answer · Medically reviewed summary · Last updated: 2026-05-08
Pontocerebellar Hypoplasia (PCH) is classified under the ICD-10 code Q04.9 (Congenital malformation of brain, unspecified) as it lacks a unique, dedicated code, while in the ICD-9 system, it is typically categorized under 742.1 (Microcephalus). Because Pontocerebellar Hypoplasia represents a heterogeneous group of rare neurodegenerative disorders, clinical coding often defaults to broader neurological malformation categories during billing and medical record documentation. What is the clinical significance of Pontocerebellar Hypoplasia? Pontocerebellar Hypoplasia is a group of rare, autosomal recessive neurodegenerative disorders characterized by impaired development of the cerebellum and the pons.
1 people with Pontocerebellar Hypoplasia have shared their first-person experience on this question at DiseaseMaps.
ICD10 code of Pontocerebellar Hypoplasia and ICD9 code
ICD-10 and ICD-9 codes for Pontocerebellar Hypoplasia, with classification details for clinicians, coders and patients.
Pontocerebellar Hypoplasia (PCH) is classified under the ICD-10 code Q04.9 (Congenital malformation of brain, unspecified) as it lacks a unique, dedicated code, while in the ICD-9 system, it is typically categorized under 742.1 (Microcephalus). Because Pontocerebellar Hypoplasia represents a heterogeneous group of rare neurodegenerative disorders, clinical coding often defaults to broader neurological malformation categories during billing and medical record documentation.
What is the clinical significance of Pontocerebellar Hypoplasia?
Pontocerebellar Hypoplasia is a group of rare, autosomal recessive neurodegenerative disorders characterized by impaired development of the cerebellum and the pons. Patients with Pontocerebellar Hypoplasia typically present with severe developmental delays, intellectual disability, and often significant motor impairment. Because it is a spectrum, the severity of symptoms varies widely between the different subtypes (PCH1 through PCH15).
How is a diagnosis of Pontocerebellar Hypoplasia confirmed?
Diagnosis is primarily achieved through neuroimaging, specifically brain MRI, which reveals the characteristic atrophy or hypoplasia of the pons and cerebellum. Genetic testing is the gold standard for confirming a Pontocerebellar Hypoplasia diagnosis, as it helps identify specific mutations (such as in the TSEN gene complex) that define the subtype. Clinical management often involves a multidisciplinary team approach to address neurological, nutritional, and respiratory needs.
Is Pontocerebellar Hypoplasia hereditary?
Yes, most forms of Pontocerebellar Hypoplasia follow an autosomal recessive inheritance pattern. This means that both parents are typically asymptomatic carriers of a genetic mutation, and there is a 25% chance for each pregnancy to be affected by the condition. Genetic counseling is highly recommended for families navigating a diagnosis of Pontocerebellar Hypoplasia to understand recurrence risks and diagnostic options.
Next steps
- Consult with a pediatric neurologist or a clinical geneticist to discuss specific subtype classification.
- Connect with the 79 members of the DiseaseMaps.org community living with or affected by Pontocerebellar Hypoplasia for peer support.
- Request a referral for early intervention services, including physical, occupational, and speech therapy.
- Visit the NIH GARD website to stay updated on emerging research and clinical trial opportunities.
Medical disclaimer: This information is for educational purposes only and does not substitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD) - Pontocerebellar hypoplasia
- Orphanet: Portal for rare diseases and orphan drugs (ORPHA:93905)
- Online Mendelian Inheritance in Man (OMIM) - Clinical synopsis of PCH subtypes
- DiseaseMaps.org: Community insights and patient-reported data
Posted Aug 10, 2017 by Benjamin Busque 2620
